Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 17

1.
2.

A prospective study of concomitant GLP-1 analogue and insulin use in type 2 diabetes in clinical practice.

van Velsen EF, Lamers J, Blok V, van Leendert RJ, Kiewiet-Kemper RM.

Neth J Med. 2014 Dec;72(10):523-7.

3.

Complementary medicine down-regulates side-effects of hormone therapy in prostate cancer patients.

Beuth J, Van Leendert R, Pempelfort K, Schneider B, Grund C, Engelmann U.

In Vivo. 2014 Sep-Oct;28(5):979-82.

PMID:
25189917
4.

Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.

Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R; LAPLACE-2 Investigators.

JAMA. 2014 May 14;311(18):1870-82. doi: 10.1001/jama.2014.4030.

PMID:
24825642
5.

Complementary medicine on side-effects of adjuvant hormone therapy in patients with breast cancer.

Beuth J, van Leendert R, Schneider B, Uhlenbruck G.

In Vivo. 2013 Nov-Dec;27(6):869-71.

PMID:
24292594
6.

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.

Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators.

Lancet. 2012 Jan 14;379(9811):123-9. doi: 10.1016/S0140-6736(11)61505-5. Epub 2011 Nov 28.

PMID:
22130488
7.

Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine.

Uhlenbruck G, VAN Leendert R, Schneider B, Beuth J.

In Vivo. 2010 Sep-Oct;24(5):799-802.

PMID:
20952754
8.

Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis.

Equinox Investigators.

J Thromb Haemost. 2011 Jan;9(1):92-9. doi: 10.1111/j.1538-7836.2010.04100.x.

PMID:
20946157
9.

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Pratley RE, Reusch JE, Fleck PR, Wilson CA, Mekki Q; Alogliptin Study 009 Group.

Curr Med Res Opin. 2009 Oct;25(10):2361-71. doi: 10.1185/03007990903156111.

PMID:
19650752
10.

[Hyponatraemia as a clinical manifestation of hypopituitarism caused by neurosarcoidosis].

de Jong PH, van Leendert RJ, de Waal M, van Bommel EF.

Ned Tijdschr Geneeskd. 2008 Nov 22;152(47):2575-9. Dutch.

PMID:
19174941
12.

Efficacy and safety of insulin glulisine in patients with type 1 diabetes.

Dreyer M, Prager R, Robinson A, Busch K, Ellis G, Souhami E, Van Leendert R.

Horm Metab Res. 2005 Nov;37(11):702-7.

PMID:
16308840
13.

Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.

Martin S, Kolb H, Beuth J, van Leendert R, Schneider B, Scherbaum WA.

Diabetologia. 2003 Dec;46(12):1611-7. Epub 2003 Nov 5.

PMID:
14600814
14.

[Pilot study of controlled retrospective analysis (retrolective study design) of care for type 2 diabetics since 1990].

Martin S, Reipen M, van Leendert R, Beuth J, Kolb H, Scherbaum WA.

Dtsch Med Wochenschr. 2003 May 23;128(21):1173-8. German.

PMID:
12761690
15.

Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.

Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.

Digestion. 2003;67(1-2):6-13. Erratum in: Digestion. 2003;67(3):128.

PMID:
12743434
16.

A patient with primary hyperparathyroidism and an abnormal bone scan.

van Leendert RJ, Flendrig JA.

Clin Nucl Med. 1986 Oct;11(10):701-3.

PMID:
3021369
17.

Successful treatment of persistent posttransplant hyperparathyroidism with diphosphonate.

Leunissen KM, Vismans FJ, van Leendert RJ, van Hooff JP.

Transplantation. 1986 May;41(5):666-7. No abstract available.

PMID:
3705163
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk